IL-12 protects from psoriasiform skin inflammation

Neutralization of the common p40-subunit of IL-12/23 in psoriasis patients has led to a breakthrough in the management of moderate to severe disease. Aside from neutralizing IL-23, which is thought to be responsible for the curative effect, anti-p40 therapy also interferes with IL-12 signalling and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulig, Paulina, Musiol, Stephanie, Freiberger, Sandra Nicole, Schreiner, Bettina, Gyülveszi, Gabor, Russo, Giancarlo, Pantelyushin, Stanislav, Kishihara, Kenji, Alessandrini, Francesca, Kündig, Thomas, Sallusto, Federica, Hofbauer, Günther F.L., Haak, Stefan, Becher, Burkhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133729/
https://www.ncbi.nlm.nih.gov/pubmed/27892456
http://dx.doi.org/10.1038/ncomms13466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133729/
https://www.ncbi.nlm.nih.gov/pubmed/27892456
http://dx.doi.org/10.1038/ncomms13466

Ejemplares similares